[Special pharmacotherapy of primary glomerulonephritis in the adult].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000925:Anticoagulants / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D004176:Dipyridamole; D003520:Cyclophosphamide; D006493:Heparin; D001379:Azathioprine; D013442:Sulfinpyrazone; D011241:Prednisone; D007213:Indomethacin
Spezielle Pharmakotherapie der primären Glomerulonephritis bei Erwachsenen